Azathioprine and low dose pulse cyclophosphamide in severe ocular lesions of Behçet's disease. A preliminary report

Adv Exp Med Biol. 2003:528:571-3. doi: 10.1007/0-306-48382-3_116.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Azathioprine / therapeutic use*
  • Behcet Syndrome / drug therapy*
  • Behcet Syndrome / physiopathology
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Prednisolone / therapeutic use
  • Retinal Vasculitis / drug therapy*
  • Retinal Vasculitis / etiology
  • Time Factors
  • Uveitis, Anterior / drug therapy*
  • Uveitis, Anterior / etiology
  • Uveitis, Posterior / drug therapy*
  • Uveitis, Posterior / etiology
  • Visual Acuity / drug effects

Substances

  • Immunosuppressive Agents
  • Cyclophosphamide
  • Prednisolone
  • Azathioprine